Ameritas Investment Partners’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $432K | Buy |
7,355
+806
| +12% | +$33.8K | 0.01% | 964 |
|
|
2026
Q1 | $211K | Hold |
6,549
| – | – | 0.01% | 1235 |
|
|
2025
Q4 | $276K | Hold |
6,549
| – | – | 0.01% | 1071 |
|
|
2025
Q3 | $225K | Sell |
6,549
-1,235
| -16% | -$35.4K | 0.01% | 1170 |
|
|
2025
Q2 | $210K | Hold |
7,784
| – | – | 0.01% | 1262 |
|
|
2025
Q1 | $231K | Hold |
7,784
| – | – | 0.01% | 1185 |
|
|
2024
Q4 | $308K | Hold |
7,784
| – | – | 0.01% | 1071 |
|
|
2024
Q3 | $265K | Buy |
7,784
+551
| +8% | +$15.5K | 0.01% | 1149 |
|
|
2024
Q2 | $157K | Hold |
7,233
| – | – | 0.01% | 1433 |
|
|
2024
Q1 | $160K | Hold |
7,233
| – | – | 0.01% | 1441 |
|
|
2023
Q4 | $199K | Hold |
7,233
| – | – | 0.01% | 1269 |
|
|
2023
Q3 | $162K | Buy |
7,233
+1,221
| +20% | +$31.4K | 0.01% | 1320 |
|
|
2023
Q2 | $153K | Buy |
6,012
+480
| +9% | +$11.6K | 0.01% | 1312 |
|
|
2023
Q1 | $123K | Hold |
5,532
| – | – | ﹤0.01% | 1398 |
|
|
2022
Q4 | $146K | Buy |
5,532
+360
| +7% | +$8.37K | 0.01% | 1341 |
|
|
2022
Q3 | $85K | Hold |
5,172
| – | – | ﹤0.01% | 1619 |
|
|
2022
Q2 | $102K | Hold |
5,172
| – | – | ﹤0.01% | 1501 |
|
|
2022
Q1 | $143K | Hold |
5,172
| – | – | 0.01% | 1406 |
|
|
2021
Q4 | $213K | Hold |
5,172
| – | – | 0.01% | 1200 |
|
|
2021
Q3 | $240K | Sell |
5,172
-308
| -6% | -$13.4K | 0.01% | 1080 |
|
|
2021
Q2 | $219K | Hold |
5,480
| – | – | 0.01% | 1178 |
|
|
2021
Q1 | $295K | Buy |
5,480
+600
| +12% | +$34.6K | 0.01% | 958 |
|
|
2020
Q4 | $239K | Hold |
4,880
| – | – | 0.01% | 1037 |
|
|
2020
Q3 | $159K | Buy |
4,880
+464
| +11% | +$14.7K | 0.01% | 1160 |
|
|
2020
Q2 | $114K | Buy |
4,416
+400
| +10% | +$9.97K | 0.01% | 1336 |
|
|
2020
Q1 | $98K | Hold |
4,016
| – | – | 0.01% | 1289 |
|
|
2019
Q4 | $112K | Hold |
4,016
| – | – | 0.01% | 1445 |
|
|
2019
Q3 | $96K | Hold |
4,016
| – | – | ﹤0.01% | 1499 |
|
|
2019
Q2 | $114K | Buy |
4,016
+1,672
| +71% | +$41.8K | 0.01% | 1417 |
|
|
2019
Q1 | $59K | Hold |
2,344
| – | – | ﹤0.01% | 1792 |
|
|
2018
Q4 | $29K | Hold |
2,344
| – | – | ﹤0.01% | 2123 |
|
|
2018
Q3 | $22K | Buy |
2,344
+950
| +68% | +$10.5K | ﹤0.01% | 2468 |
|
|
2018
Q2 | $13K | Hold |
1,394
| – | – | ﹤0.01% | 2745 |
|
|
2018
Q1 | $8K | Hold |
1,394
| – | – | ﹤0.01% | 2793 |
|
|
2017
Q4 | $9K | Hold |
1,394
| – | – | ﹤0.01% | 2788 |
|
|
2017
Q3 | $11K | Hold |
1,394
| – | – | ﹤0.01% | 2743 |
|
|
2017
Q2 | $12K | Buy |
1,394
+950
| +214% | +$7.75K | ﹤0.01% | 2761 |
|
|
2017
Q1 | $4K | Buy |
+444
| New | +$3.63K | ﹤0.01% | 2880 |
|
Other funds holding VCYT
AIM
Ameritas Investment Partners's VCYT Position: Q2 2026 in Review
Ameritas Investment Partners increased its Veracyte (VCYT) stake by 12% in Q2 2026, buying an estimated $33.8K and bringing the position to 7,355 shares worth $432K. The position accounts for 0.01% of the portfolio, ranked #964.
Ameritas Investment Partners first reported a position in VCYT in Q1 2017 and has held it in 38 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Ameritas Investment Partners held 7,355 shares of Veracyte worth $432K as of Q2 2026.
- Ameritas Investment Partners bought 806 Veracyte shares in Q2 2026, an estimated $33.8K.
- Veracyte made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #964 holding.
- Ameritas Investment Partners first reported a position in Veracyte in Q1 2017 and has held it in 38 quarters since.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.